First Trust NYSE Arca Biotechnology Index Fund
222 hedge funds and large institutions have $588M invested in First Trust NYSE Arca Biotechnology Index Fund in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 45 increasing their positions, 84 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
11% less capital invested
Capital invested by funds: $662M → $588M (-$74.5M)
46% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 84
Holders
222
Holding in Top 10
3
Calls
$1.75M
Puts
–
Top Buyers
| 1 | +$8.01M | |
| 2 | +$4.78M | |
| 3 | +$3.95M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.79M |
| 5 |
MML Investors Services
Springfield,
Massachusetts
|
+$1.94M |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$5.64M | |
| 3 | -$4.59M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3.06M |
| 5 |
LPL Financial
San Diego,
California
|
-$2.75M |